Leidos (NYSE:LDOS – Get Rating) had its price target increased by The Goldman Sachs Group from $103.00 to $118.00 in a research note issued to investors on Tuesday, Analyst Ratings Network reports. They currently have a buy rating on the aerospace company’s stock. Several other brokerages also recently commented on LDOS. Barclays reduced their price […]
Galapagos (NASDAQ:GLPG – Get Rating) had its price target lifted by equities researchers at Morgan Stanley from $77.00 to $80.00 in a report issued on Monday, Analyst Ratings Network reports. The firm presently has an “overweight” rating on the biotechnology company’s stock. Morgan Stanley’s price target would indicate a potential upside of 20.66% from the […]
Berkeley Lights (NASDAQ:BLI – Get Rating) had its price objective lowered by Morgan Stanley from $20.00 to $14.00 in a research note published on Friday morning, Analyst Ratings Network reports. The brokerage currently has an equal weight rating on the stock. Other equities research analysts have also issued reports about the company. Stifel Nicolaus lowered […]
MacroGenics (NASDAQ:MGNX – Get Rating) had its target price decreased by SVB Leerink from $40.00 to $23.00 in a research report sent to investors on Friday, Analyst Ratings Network reports. SVB Leerink currently has an outperform rating on the biopharmaceutical company’s stock. Several other research analysts have also recently commented on MGNX. BMO Capital Markets […]
CS Disco (NYSE:LAW – Get Rating) had its price objective lowered by Cowen from $50.00 to $45.00 in a research note released on Friday, Analyst Ratings Network reports. The firm currently has an outperform rating on the stock. Several other research analysts have also recently weighed in on LAW. Jefferies Financial Group upgraded CS Disco […]